Occurrence of Acute Cardiovascular Events in Transgender Individuals Receiving Hormone Therapy

Circulation. 2019 Mar 12;139(11):1461-1462. doi: 10.1161/CIRCULATIONAHA.118.038584.

Authors

Nienke M Nota¹, Chantal M Wiepjes¹, Christel J M de Blok¹, Louis J G Gooren¹, Baudewijntje P C Kreukels², Martin den Heijer¹

Affiliations

¹ Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Department of Internal Medicine, Division of Endocrinology, the Netherlands (N.M.N., C.M.W., C.J.M.d.B., L.J.G.G., M.d.H.).
² Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Department of Medical Psychology, Amsterdam Public Health, the Netherlands (B.P.C.K.).

PMID: 30776252
DOI: 10.1161/CIRCULATIONAHA.118.038584

No abstract available

Keywords: hormones; myocardial infarction; stroke; transgender persons; venous thromboembolism.

Publication types

Comparative Study
Letter

MeSH terms

Adult
Androgen Antagonists / adverse effects
Cardiovascular Diseases / chemically induced*
Cardiovascular Diseases / diagnosis
Cardiovascular Diseases / epidemiology
Estrogens / adverse effects*
Female
Humans
Incidence
Male
Prognosis
Risk Assessment
Risk Factors
Testosterone / adverse effects*
Time Factors
Transgender Persons*
Transsexualism / diagnosis
Transsexualism / drug therapy*
Transsexualism / physiopathology
Young Adult

Substances

Androgen Antagonists
Estrogens
Testosterone